Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
2012 · Journal of Hepatology · 286 citations
https://doi.org/10.1016/j.jhep.2012.07.030
L
Linda Andersson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
76
Papers
2.9K
Citations
25
h-index
39
i10-index
Linda Andersson is an academic researcher from Helsinki University Hospital. The author has contributed to research in topics: Lipid metabolism and biosynthesis & Diabetes, Cardiovascular Risks, and Lipoproteins & Chemical Synthesis and Analysis. The author has an h-index of 25, co-authored 65 publications.
ORCID: 0000-0003-3230-5397Papers by this author
worksInvestigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
2019 · Journal of Internal Medicine · 49 citations
https://doi.org/10.1111/joim.12877
Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL
2005 · Journal of Lipid Research · 32 citations
https://doi.org/10.1194/jlr.m500424-jlr200
Deficiency in perilipin 5 reduces mitochondrial function and membrane depolarization in mouse hearts
2017 · The International Journal of Biochemistry & Cell Biology · 23 citations
https://doi.org/10.1016/j.biocel.2017.07.021
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy
2023 · Diabetologia · 19 citations
https://doi.org/10.1007/s00125-023-06008-0
Protocolized reduction of non-resuscitation fluids versus usual care in septic shock patients (REDUSE): a randomized multicentre feasibility trial
2024 · Critical Care · 9 citations
https://doi.org/10.1186/s13054-024-04952-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat